Clinical Trial Update: ProF-001_Phase IIa [Phase 2, Phase 3]

View source ↗

Summary

Phase IIa/III clinical trial update for ProF-001 in vulvovaginal candidiasis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• ProF-001

Snippet

Sponsor: ProFem GmbH | Conditions: Vulvovaginal Candidiasis (VVC) | Phase 2, Phase 3 | Status: COMPLETED